LMR for Prognosis of Radioiodine-Refractory Thyroid Cancer LMR for Prognosis of Radioiodine-Refractory Thyroid Cancer
Find out how the lymphocyte-to-monocyte ratio may aid in the prognosis of patients with progressive radioiodine-refractory differentiated thyroid carcinoma.Clinical Endocrinology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Diabetes | Endocrinology | Health | Thyroid | Thyroid Cancer